Year archive

Karolinska Development — 2014 filings

All 55 regulatory filings released by Karolinska Development (KDEV) in 2014, sourced directly from the official regulator.

55 Filings

2014 Period

2014 filings (55)

Filing	Released	Lang
Karolinska Development offentliggör utfallet i företrädesemissionen av konvertibler Capital/Financing Update	2014-12-30	Swedish
Karolinska Development announces outcome of the rights issue of convertibles Capital/Financing Update	2014-12-30	English
Major Shareholding Notification 2014 Major Shareholding Notification	2014-12-15	English
Purchase of own shares to cover social security fees related to incentive program Transaction in Own Shares	2014-12-08	English
Återköp av egna aktier för att täcka sociala avgifter kopplade till incitamentsprogram Transaction in Own Shares	2014-12-08	Swedish
Prospekt avseende inbjudan till teckning av konvertibler i Karolinska Development AB offentliggjort Report Publication Announcement	2014-12-05	Swedish
Karolinska Developments extra bolagsstämma Share Issue/Capital Change	2014-12-04	Swedish
Karolinska Development’s Extraordinary General Meeting AGM Information	2014-12-04	English
Karolinska Development offentliggör åtaganden och avsikter att stödja de föreslagna konvertibelemissionerna Capital/Financing Update	2014-12-03	Swedish
Optionsrätt med Athera kommer inte att utnyttjas efter förändring av Boehringer Ingelheims FoU-strategi - kliniska utvecklingen av Atheras antikropp fortsätter som planerat M&A Activity	2014-11-12	Swedish
The option rights with Athera will not be exercised due to re-evaluation of Boehringer Ingelheim’s R&D strategy – clinical development of Athera’s antibody proceeds as planned Regulatory Filings	2014-11-12	English
Karolinska Development secures funding from CP Group, a leading Asian life science investor, and initiates preparation for a convertible bond issue Capital/Financing Update	2014-11-05	English
Karolinska Development säkrar finansiering från CP Group, en ledande asiatisk life science-investerare, samt förbereder för en konvertibelemission Share Issue/Capital Change	2014-11-05	Swedish
Forendo Pharma slutför finansiering som tillför 12 miljoner euro för utveckling av ny behandling inom endometrios Share Issue/Capital Change	2014-10-22	Swedish
Forendo Pharma closes EUR 12 million Series A financing round to develop a novel targeted therapy for endometriosis Share Issue/Capital Change	2014-10-22	English
Earnings Release 2014 Earnings Release 9M 2014	2014-10-21	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report 9M 2014	2014-10-21	English
Athera initiates Phase I trial with its fully human antibody PC-mAb Regulatory Filings	2014-10-21	English
Athera inleder fas I-studie med bolagets humana antikropp PC-mAb Regulatory Filings	2014-10-21	Swedish
OssDsigns Cranioplug får marknadsgodkännande i USA Regulatory Filings	2014-10-20	Swedish
OssDsign’s Cranioplug receives marketing approval in the US Regulatory Filings	2014-10-20	English
Bruno Lucidi appointed permanent CEO of Karolinska Development Board/Management Information	2014-10-15	English
Bruno Lucidi utnämnd till permanent VD för Karolinska Development Board/Management Information	2014-10-15	Swedish
Karolinska Development bjuder in till kapitalmarknadsdag och tidigarelägger rapporten för tredje kvartalet Report Publication Announcement	2014-09-30	Swedish
Karolinska Development invites to a Capital Markets Day and brings the third quarter report forward Report Publication Announcement	2014-09-30	English
Umecrine Mood rapporterar positiva resultat från en explorativ fas I/II-studie med UC1010 för behandling av premenstruell dysforiskt syndrom (PMDS) Earnings Release FY 2014	2014-09-19	Swedish
Umecrine Mood announces positive results from an exploratory Phase I/II study with UC1010 in premenstrual dysphoric disorder (PMDD) Earnings Release FY 2014	2014-09-19	English
Interim / Quarterly Report 2014 Interim / Quarterly Report H1 2014	2014-08-21	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report H1 2014	2014-08-21	English
Umecrine Mood rapporterar preliminära data från en explorativ fas II-studie i premenstruell dysforiskt syndrom (PMDS) Earnings Release FY 2014	2014-06-12	Swedish
Umecrine Mood reports preliminary data from exploratory Phase II study in premenstrual dysphoric disorder (PMDD) Earnings Release FY 2014	2014-06-12	English
Dilaforette AB presenterar resultat från explorativ fas I/II-studie i okomplicerad malaria Earnings Release FY 2014	2014-05-30	Swedish
Dilaforette presents results from exploratory Phase I/II clinical trial in uncomplicated malaria Regulatory Filings	2014-05-30	English
Karolinska Developments årsstämma 2014 AGM Information	2014-05-15	Swedish
Karolinska Development´s Annual General Meeting 2014 AGM Information	2014-05-15	English
XSpray Announces Positive Phase I Data for HyNap™ Nilotinib Regulatory Filings	2014-05-08	English
XSpray rapporterar positiva fas I-data för HyNap™ nilotinib Earnings Release FY 2014	2014-05-08	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-08	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-05-08	English
Dosering påbörjad i fas I/II-studie med APR-246 vid äggstockscancer Regulatory Filings	2014-04-16	Swedish
Dosing initiated in Phase I/II clinical trial of APR-246 in ovarian cancer Regulatory Filings	2014-04-16	English
Annual Report 2013 Annual Report FY 2013	2014-04-10	Swedish
Annual Report 2013 Annual Report FY 2013	2014-04-10	English
Notice of Annual General Meeting in Karolinska Development AB (publ) AGM Information	2014-04-09	English
Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma AGM Information	2014-04-09	Swedish
Nya studiedata pekar på att SHACT kan underlätta för kvinnor som genomgår hysteroskopi Regulatory Filings	2014-03-25	Swedish
New trial data suggest that SHACT could benefit women undergoing hysteroscopies Regulatory Filings	2014-03-25	English
Dilafor enters into a license and partnership agreement with Lee’s Pharmaceutical Regulatory Filings	2014-02-20	English
Dilafor ingår licens- och partnerskapsavtal med Lee’s Pharmaceutical Capital/Financing Update	2014-02-20	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report FY 2013	2014-02-19	Swedish
Audit Report / Information 2013 Audit Report / Information FY 2013	2014-02-19	English
Karolinska Development AB utser ny finansdirektör Board/Management Information	2014-01-28	Swedish
Karolinska Development AB appoints new Chief Financial Officer Board/Management Information	2014-01-28	English
NovaSAID initiates partnership with Cadila Pharmaceuticals to develop innovative treatments in inflammation and pain management Regulatory Filings	2014-01-10	English
NovaSAID inleder samarbete med Cadila Pharmaceuticals för utveckling av nya behandlingar av inflammation och smärta Regulatory Filings	2014-01-10	Swedish

Filings by year

2026 19 filings
2025 20 filings
2024 25 filings
2023 18 filings
2022 26 filings
2021 41 filings
2020 40 filings
2019 187 filings
2018 34 filings
2017 66 filings
2016 42 filings
2015 53 filings
2014 55 filings
2013 54 filings
2012 40 filings
2011 41 filings